34.15 USD
+0.93 (+2.8%)
At close: Feb 6, 2026
34.15 USD
0 (0%)
After Hours: 2/6/2026, 8:04:20 PM
Taking everything into account, RIGL scores 7 out of 10 in our fundamental rating. RIGL was compared to 523 industry peers in the Biotechnology industry. While RIGL has a great health rating, its profitability is only average at the moment. RIGL is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make RIGL suitable for value and growth investing!
1. Profitability
1.1 Basic Checks
- In the past year RIGL was profitable.
- In the past year RIGL had a positive cash flow from operations.
- In the past 5 years RIGL reported 4 times negative net income.
- The reported operating cash flow has been mixed in the past 5 years: RIGL reported negative operating cash flow in multiple years.
1.2 Ratios
- RIGL has a better Return On Assets (46.72%) than 99.43% of its industry peers.
- The Return On Equity of RIGL (96.34%) is better than 99.43% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 63.44%, RIGL belongs to the top of the industry, outperforming 99.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 46.72% | ||
| ROE | 96.34% | ||
| ROIC | 63.44% |
ROA(3y)-18.12%
ROA(5y)-18.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- RIGL's Profit Margin of 40.17% is amongst the best of the industry. RIGL outperforms 96.95% of its industry peers.
- RIGL has a better Operating Margin (42.17%) than 98.86% of its industry peers.
- With an excellent Gross Margin value of 93.10%, RIGL belongs to the best of the industry, outperforming 93.71% of the companies in the same industry.
- RIGL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.17% | ||
| PM (TTM) | 40.17% | ||
| GM | 93.1% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-1.87%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RIGL is creating value.
- The number of shares outstanding for RIGL has been increased compared to 1 year ago.
- Compared to 5 years ago, RIGL has less shares outstanding
- RIGL has a better debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -1.10, we must say that RIGL is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -1.10, RIGL is in line with its industry, outperforming 55.81% of the companies in the same industry.
- The Debt to FCF ratio of RIGL is 0.88, which is an excellent value as it means it would take RIGL, only 0.88 years of fcf income to pay off all of its debts.
- RIGL has a Debt to FCF ratio of 0.88. This is amongst the best in the industry. RIGL outperforms 93.90% of its industry peers.
- RIGL has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.25, RIGL is doing worse than 66.10% of the companies in the same industry.
- Although RIGL does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 0.88 | ||
| Altman-Z | -1.1 |
ROIC/WACC7.03
WACC9.02%
2.3 Liquidity
- A Current Ratio of 2.28 indicates that RIGL has no problem at all paying its short term obligations.
- The Current ratio of RIGL (2.28) is worse than 72.76% of its industry peers.
- RIGL has a Quick Ratio of 2.14. This indicates that RIGL is financially healthy and has no problem in meeting its short term obligations.
- RIGL has a worse Quick ratio (2.14) than 72.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.28 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
- RIGL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4307.14%, which is quite impressive.
- The Revenue has grown by 79.13% in the past year. This is a very strong growth!
- Measured over the past years, RIGL shows a very strong growth in Revenue. The Revenue has been growing by 24.77% on average per year.
EPS 1Y (TTM)4307.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108.57%
Revenue 1Y (TTM)79.13%
Revenue growth 3Y6.31%
Revenue growth 5Y24.77%
Sales Q2Q%25.59%
3.2 Future
- RIGL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.43% yearly.
- The Revenue is expected to grow by 15.70% on average over the next years. This is quite good.
EPS Next Y617.8%
EPS Next 2Y102.8%
EPS Next 3Y73.32%
EPS Next 5Y45.43%
Revenue Next Year68.61%
Revenue Next 2Y26.11%
Revenue Next 3Y22.67%
Revenue Next 5Y15.7%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 5.53, the valuation of RIGL can be described as very cheap.
- RIGL's Price/Earnings ratio is rather cheap when compared to the industry. RIGL is cheaper than 99.05% of the companies in the same industry.
- When comparing the Price/Earnings ratio of RIGL to the average of the S&P500 Index (27.93), we can say RIGL is valued rather cheaply.
- The Price/Forward Earnings ratio is 8.83, which indicates a very decent valuation of RIGL.
- RIGL's Price/Forward Earnings ratio is rather cheap when compared to the industry. RIGL is cheaper than 98.67% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 27.77. RIGL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.53 | ||
| Fwd PE | 8.83 |
4.2 Price Multiples
- RIGL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. RIGL is cheaper than 99.24% of the companies in the same industry.
- RIGL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RIGL is cheaper than 98.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.1 | ||
| EV/EBITDA | 3.74 |
4.3 Compensation for Growth
- RIGL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- RIGL has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as RIGL's earnings are expected to grow with 73.32% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y102.8%
EPS Next 3Y73.32%
5. Dividend
5.1 Amount
- No dividends for RIGL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
34.15
+0.93 (+2.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)03-02 2026-03-02/amc
Inst Owners85.11%
Inst Owner Change1.65%
Ins Owners2.59%
Ins Owner Change-2.69%
Market Cap619.82M
Revenue(TTM)282.08M
Net Income(TTM)113.30M
Analysts80
Price Target47.94 (40.38%)
Short Float %20.94%
Short Ratio7.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.05%
Min EPS beat(2)24.64%
Max EPS beat(2)67.46%
EPS beat(4)4
Avg EPS beat(4)188.12%
Min EPS beat(4)24.64%
Max EPS beat(4)592.43%
EPS beat(8)7
Avg EPS beat(8)242.36%
EPS beat(12)11
Avg EPS beat(12)181.29%
EPS beat(16)14
Avg EPS beat(16)138.58%
Revenue beat(2)2
Avg Revenue beat(2)11.07%
Min Revenue beat(2)10.05%
Max Revenue beat(2)12.08%
Revenue beat(4)4
Avg Revenue beat(4)12.62%
Min Revenue beat(4)9.15%
Max Revenue beat(4)19.17%
Revenue beat(8)7
Avg Revenue beat(8)10.41%
Revenue beat(12)11
Avg Revenue beat(12)14.43%
Revenue beat(16)12
Avg Revenue beat(16)11.18%
PT rev (1m)3.68%
PT rev (3m)22.61%
EPS NQ rev (1m)9.34%
EPS NQ rev (3m)23.62%
EPS NY rev (1m)0.92%
EPS NY rev (3m)19.02%
Revenue NQ rev (1m)2.23%
Revenue NQ rev (3m)3.1%
Revenue NY rev (1m)0.51%
Revenue NY rev (3m)4.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.53 | ||
| Fwd PE | 8.83 | ||
| P/S | 2.2 | ||
| P/FCF | 9.1 | ||
| P/OCF | 9.09 | ||
| P/B | 5.27 | ||
| P/tB | 6.72 | ||
| EV/EBITDA | 3.74 |
EPS(TTM)6.17
EY18.07%
EPS(NY)3.87
Fwd EY11.32%
FCF(TTM)3.75
FCFY10.99%
OCF(TTM)3.76
OCFY11%
SpS15.54
BVpS6.48
TBVpS5.08
PEG (NY)0.01
PEG (5Y)N/A
Graham Number29.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 46.72% | ||
| ROE | 96.34% | ||
| ROCE | 80.3% | ||
| ROIC | 63.44% | ||
| ROICexc | 854.98% | ||
| ROICexgc | N/A | ||
| OM | 42.17% | ||
| PM (TTM) | 40.17% | ||
| GM | 93.1% | ||
| FCFM | 24.16% |
ROA(3y)-18.12%
ROA(5y)-18.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-1.87%
F-Score7
Asset Turnover1.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 0.88 | ||
| Debt/EBITDA | 0.25 | ||
| Cap/Depr | 1.57% | ||
| Cap/Sales | 0.01% | ||
| Interest Coverage | 17.61 | ||
| Cash Conversion | 56.17% | ||
| Profit Quality | 60.14% | ||
| Current Ratio | 2.28 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z | -1.1 |
F-Score7
WACC9.02%
ROIC/WACC7.03
Cap/Depr(3y)424.8%
Cap/Depr(5y)301.24%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4307.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108.57%
EPS Next Y617.8%
EPS Next 2Y102.8%
EPS Next 3Y73.32%
EPS Next 5Y45.43%
Revenue 1Y (TTM)79.13%
Revenue growth 3Y6.31%
Revenue growth 5Y24.77%
Sales Q2Q%25.59%
Revenue Next Year68.61%
Revenue Next 2Y26.11%
Revenue Next 3Y22.67%
Revenue Next 5Y15.7%
EBIT growth 1Y1151.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year546.96%
EBIT Next 3Y91.91%
EBIT Next 5Y95.89%
FCF growth 1Y286.79%
FCF growth 3Y80.89%
FCF growth 5YN/A
OCF growth 1Y418.44%
OCF growth 3Y74.92%
OCF growth 5YN/A
RIGEL PHARMACEUTICALS INC / RIGL FAQ
What is the ChartMill fundamental rating of RIGEL PHARMACEUTICALS INC (RIGL) stock?
ChartMill assigns a fundamental rating of 7 / 10 to RIGL.
What is the valuation status for RIGL stock?
ChartMill assigns a valuation rating of 9 / 10 to RIGEL PHARMACEUTICALS INC (RIGL). This can be considered as Undervalued.
Can you provide the profitability details for RIGEL PHARMACEUTICALS INC?
RIGEL PHARMACEUTICALS INC (RIGL) has a profitability rating of 6 / 10.
How financially healthy is RIGEL PHARMACEUTICALS INC?
The financial health rating of RIGEL PHARMACEUTICALS INC (RIGL) is 7 / 10.